Godrej Industries Q4 Results: Company Swings To Profit, Revenue Rises 27%

Godrej Industries Ltd. swung back to profit in the fourth quarter of financial year 2024–25, as per the results declared by the conglomerate on Thursday.

The consolidated bottom line came in at Rs 183 crore in the January–March period, as against a net loss of Rs 311.8 crore in the year-ago quarter.

The revenue from operations rose 26.5% to Rs 5,780 crore, as compared to Rs 4,567 crore in the corresponding quarter of the preceding fiscal.

The operating profit, or the earnings before interest, taxes, depreciation and amortisation rose 29.4% to Rs 593.5 crore as against Rs 458.5 crore in the year-ago quarter.

The margin expanded by 30 basis points to 10.3%. One basis point is hundredth of a percentage point.

• Margin expands to 10.3% versus 10%

• Ebitda rises 29.4% to Rs 593.5 crore versus Rs 458.5 crore

• Revenue up 26.5% at Rs 5,780 crore versus Rs 4,567 crore

• Net Profit at Rs 183 crore versus loss of Rs 311.8 crore

The home care segment grew 14% and household insecticides delivered a double-digit growth, pushed by a good season and strong market-share gains. Both air fresheners and fabric care delivered strong double-digit volume growth.

Personal care segment saw a 4% uptick but the personal wash volumes declined during the quarter. Magic Handwash and Godrej Expert Rich Crème packs continued to grow in double-digits.

The chemicals business saw a 42% uptick in revenue for the quarter and export account for 30% of the same. In the real estate business, Godrej Properties Ltd., delivered 18.4 million sq ft of projects this year across five cities, marking a 47% growth year on year.

The total income of the agri business stood at Rs 2,147 crore for the quarter, according to the company's press release.

Before the quarterly results were declared, shares of Godrej Industries closed 3.91% lower at Rs 1,126.7 apiece on the NSE, compared to a 1.60% advance in the benchmark Nifty 50. The company's shares have risen 40.93% in the last 12 months and declined 3.39% on a year-to-date basis.

An analyst tracking the company has a 'buy' rating on the stock, according to Bloomberg data.